Sfoglia per AUTORE
OWEN DH
Collezione AOU San Luigi di Orbassano
Items : 2
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1?50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry. in Journal for immunotherapy of cancer / J Immunother Cancer. 2025 Feb 4;13(2):e010674. doi: 10.1136/jitc-2024-010674.
2025
AOU San Luigi di Orbassano
AOU Novara
AOU San Luigi di Orbassano
AOU Novara
Wakelee H; Garassino M; Peters S; Takada K; Naqash AR; Torri V; Hejleh TA; Ferrara R; Aerts JGJV; Aboubakar Nana F; Dingemans AM; Biello F; Rogado J; Moliner L; Beninato T; Lo Russo G; Servetto A; Mezquita L; Gorría T; Minuti G; Bennati C; Tonini G; Cortinovis DL; Agustoni F; Majem M; Baena J; Macerelli M; Monnet I; O'Reilly D; et alii...
Expert consensus on perioperative treatment for non-small cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Jul;11(7):1247-1267. doi: 10.21037/tlcr-22-527.
2022
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Duan J; Tan F; Bi N; Chen C; Chen KN; Cheng Y; Chu Q; Ge D; Hu J; Huang Y; Jiang T; Long H; Lu Y; Shi M; Wang J; Wang Q; Yang F; Yang N; Yao Y; Ying J; Zhou C; Zhou Q; Zhou Q; Bongiolatti S; Brunelli A; Fiorelli A; Gobbini E; Gridelli C; John T; et alii...